These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1091976)

  • 41. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Central nervous system involvement in systemic lupus erythematosus].
    Zhang X; Dong Y; Tang F; Li H; Zhang F
    Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):681-4. PubMed ID: 11798707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuro-ophthalmologic manifestations of systemic lupus erythematosus: a systematic review.
    Man BL; Mok CC; Fu YP
    Int J Rheum Dis; 2014 Jun; 17(5):494-501. PubMed ID: 24673755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
    Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
    Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic lupus erythematosus within the first two decades of life.
    Fish AJ; Blau EB; Westberg NG; Burke BA; Vernier RL; Michael AF
    Am J Med; 1977 Jan; 62(1):99-117. PubMed ID: 835595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Psychiatric manifestations in lupus erythematosus].
    Julien CG
    Encephale; 1970; 59(4):291-312. PubMed ID: 5481585
    [No Abstract]   [Full Text] [Related]  

  • 47. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
    Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Problems posed by the treatment of neurologic and neuropsychic manifestations of systemic lupus erythematosus].
    Corvol P; Lagrue G; Marteau R; Milliez P
    Therapeutique; 1972; 48(7):492-7. PubMed ID: 4640270
    [No Abstract]   [Full Text] [Related]  

  • 49. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
    Tanaka E; Harigai M; Tanaka M; Kawaguchi Y; Hara M; Kamatani N
    J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
    Kelly MC; Denburg JA
    J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections.
    Tsai CY; Wu TH; Tsai ST; Chen KH; Thajeb P; Lin WM; Yu HS; Yu CL
    Scand J Rheumatol; 1994; 23(2):57-63. PubMed ID: 8165438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus.
    Sibley JT; Olszynski WP; Decoteau WE; Sundaram MB
    J Rheumatol; 1992 Jan; 19(1):47-52. PubMed ID: 1556699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dilemmas in neuropsychiatric lupus.
    Kovacs JA; Urowitz MB; Gladman DD
    Rheum Dis Clin North Am; 1993 Nov; 19(4):795-814. PubMed ID: 8265823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Systemic manifestations of Parvovirus B19 infections].
    Sève P; Ferry T; Charhon A; Calvet A; Broussolle C
    Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus.
    Colasanti T; Delunardo F; Margutti P; Vacirca D; Piro E; Siracusano A; Ortona E
    J Neuroimmunol; 2009 Jul; 212(1-2):3-9. PubMed ID: 19500858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
    Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
    J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria.
    Sciascia S; Bertolaccini ML; Baldovino S; Roccatello D; Khamashta MA; Sanna G
    Autoimmun Rev; 2013 Jan; 12(3):426-9. PubMed ID: 22944298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations.
    Tincani A; Brey R; Balestrieri G; Vitali C; Doria A; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S23-9. PubMed ID: 9049450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy.
    Meehan RT; Dorsey JK
    J Rheumatol; 1987 Apr; 14(2):252-8. PubMed ID: 3598995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.